These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 10582458)

  • 1. Dealing with a special group: hypertrophic cardiomyopathy. Pharmacological treatment.
    Brito D
    Rev Port Cardiol; 1999 Sep; 18 Suppl 5():V47-9. PubMed ID: 10582458
    [No Abstract]   [Full Text] [Related]  

  • 2. Perhexiline and hypertrophic cardiomyopathy: a new horizon for metabolic modulation.
    Horowitz JD; Chirkov YY
    Circulation; 2010 Oct; 122(16):1547-9. PubMed ID: 20921436
    [No Abstract]   [Full Text] [Related]  

  • 3. [Controversies in hypertrophic cardiomyopathy].
    Hardarson T
    Laeknabladid; 2009 Sep; 95(9):555. PubMed ID: 19738289
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of hypertrophic cardiomyopathy.
    Hopf R; Kaltenbach M
    Annu Rev Med; 1990; 41():75-83. PubMed ID: 2184751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midodrine hydrochloride and unexpected improvement in hypertrophic cardiomyopathy symptoms.
    Lafitte S; Peyrou J; Reynaud A; Dijos M; Cornolle C; Roudaut R; Touche C; Ritter P; Réant P
    Arch Cardiovasc Dis; 2016 Mar; 109(3):223-5. PubMed ID: 26898633
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hypertrophic cardiomyopathy with restrictive pathophysiology: is there a role for cardiopulmonary exercise testing?].
    Correale M; Passero T; Totaro A; Di Biase M
    G Ital Cardiol (Rome); 2012 Dec; 13(12):861; author's reply p.861. PubMed ID: 23196690
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypertrophic cardiomyopathy: therapeutic approaches.
    Thomas B
    Heart Dis; 1999; 1(2):91-7. PubMed ID: 11720609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of symptomatic hypertrophic cardiomyopathy: pills, alcohol, or the scalpel?
    Gersh BJ; Nishimura RA
    Rev Esp Cardiol (Engl Ed); 2014 May; 67(5):341-4. PubMed ID: 24774724
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathophysiology and treatment of hypertrophic cardiomyopathy.
    Sherrid MV
    Prog Cardiovasc Dis; 2006; 49(2):123-51. PubMed ID: 17046437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New perspectives in the pharmacological treatment of hypertrophic cardiomyopathy.
    Maltês S; Lopes LR
    Rev Port Cardiol (Engl Ed); 2020 Feb; 39(2):99-109. PubMed ID: 32245685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of symptoms in hypertrophic cardiomyopathy.
    Fifer MA; Vlahakes GJ
    Circulation; 2008 Jan; 117(3):429-39. PubMed ID: 18212300
    [No Abstract]   [Full Text] [Related]  

  • 12. September 2016 at a glance: pregnancy, hypertrophic cardiomyopathy, epidemiology, medical treatment.
    Metra M
    Eur J Heart Fail; 2016 Sep; 18(9):1091-2. PubMed ID: 27594173
    [No Abstract]   [Full Text] [Related]  

  • 13. Dealing with a special group: hypertrophic cardiomyopathy. The role of electrophysiology and pacing in hypertrophic cardiomyopathy.
    de Sousa J
    Rev Port Cardiol; 1999 Sep; 18 Suppl 5():V51-3. PubMed ID: 10582459
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypertrophic cardiomyopathy. Pathophysiology, diagnosis, and treatment.
    Popjes ED; St John Sutton M
    Geriatrics; 2003 Mar; 58(3):41-6; quiz 47. PubMed ID: 12650117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On the work by S. Reith and H. G. Klues "Therapy and risk-stratification in hypertrophic cardiomyopathy", Z Kardiol 92: 283-293 (2003)].
    Schwab J; Bareiter T; Bär I; Gottwik M
    Z Kardiol; 2003 Sep; 92(9):763. PubMed ID: 14508595
    [No Abstract]   [Full Text] [Related]  

  • 16. [The electrocardiogram in apical hypertrophic myocardiopathy. A case report with unique manifestations].
    Penas Lado M; Mosquera Pérez I; Bouzas Zubeldía B; Vázquez Rodríguez JM; Castro Beiras A
    Rev Esp Cardiol; 1999 Dec; 52(12):1148-50. PubMed ID: 10659661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sixty Years of Hemodynamic Pharmacology in Obstructive Hypertrophic Cardiomyopathy.
    Ommen SR
    N Engl J Med; 2024 May; 390(20):1914-1915. PubMed ID: 38739083
    [No Abstract]   [Full Text] [Related]  

  • 18. Dealing with a special group: hypertrophic cardiomyopathy. Etiology and prevalence: what is known today.
    Komajda M
    Rev Port Cardiol; 1999 Sep; 18 Suppl 5():V41-4. PubMed ID: 10582456
    [No Abstract]   [Full Text] [Related]  

  • 19. HMG CoA reductase inhibition and left ventricular mass in hypertrophic cardiomyopathy: a randomized placebo-controlled pilot study.
    Bauersachs J; Störk S; Kung M; Waller C; Fidler F; Hoyer C; Frantz S; Weidemann F; Ertl G; Angermann CE
    Eur J Clin Invest; 2007 Nov; 37(11):852-9. PubMed ID: 17973781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sudden cardiac death due to hypertrophic cardiomyopathy can be reduced by pre-participation cardiovascular screening in young athletes.
    Panhuyzen-Goedkoop NM; Verheugt FW
    Eur Heart J; 2006 Sep; 27(18):2152-3. PubMed ID: 16877480
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.